콜마비앤에이치
Financials
Valuation Metrics
콜마비앤에이치's Market Cap is ₩2121B. At end of 2025 it was ₩3683B. Ranked #763 of 2,405 in KR market (top 32%), #340 of 1,627 on KOSDAQ (top 21%), #19 of 56 in Household & Personal Products (top 34%) by Market Cap.
Investment Metrics(as of 2026-11-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 212.08B KRW | KR#763/2,405 Sec#19/56 |
| Revenue | 538.18B KRW | KR#593/2,405 Sec#12/56 |
| Net Income | -1.48B KRW | KR—/2,405 Sec—/56 |
| Total Assets | 570.69B KRW | KR#714/2,405 Sec#11/56 |
| Net Assets | 382.68B KRW | KR#611/2,405 Sec#10/56 |
| Employees | 528 | KR#468/2,405 Sec#10/56 |
| Value | ||
| P/B | 0.55x | KR#998/2,405 Sec#20/56 |
| P/S | 0.39x | KR#830/2,405 Sec#13/56 |
| EV/EBITDA | 7.43x | KR#483/2,405 Sec#10/56 |
| FCF Yield | 10.59% | KR#628/2,405 Sec#11/56 |
| Profitability | ||
| ROE | -0.39% | KR#1,574/2,405 Sec#37/56 |
| ROA | -0.26% | KR#1,580/2,405 Sec#37/56 |
| Op. Margin | 6.10% | KR#825/2,405 Sec#21/56 |
| Revenue Growth | -8.83% | KR#1,891/2,405 Sec#44/56 |
| Financial Health | ||
| Debt Ratio | 49.13% | KR#945/2,405 Sec#27/56 |
| Total Debt | 108.06B KRW | KR#698/2,405 Sec#11/56 |
| FCF | 22.45B KRW | KR#486/2,405 Sec#12/56 |
| Cash | 76.12B KRW | KR#575/2,405 Sec#15/56 |
| Current Ratio | 2.52x | KR#678/2,405 Sec#17/56 |
| Net Debt/EBITDA | 0.97x | KR#731/2,405 Sec#20/56 |
| Dividend | ||
| Div. Yield | 9.23% | KR#63/2,405 Sec#1/56 |
| Div. Growth | -75.65% | KR—/2,405 Sec—/56 |
| Performance | ||
| 1Y Return | -46.13% | KR#1,861/2,405 Sec#42/56 |
| 1M Return | -8.33% | KR#826/2,405 Sec#21/56 |
| From 52W High | -51.35% | KR#1,193/2,405 Sec#31/56 |
| 1Y MDD | -51.71% | KR#1,024/2,405 Sec#32/56 |
| Trading | ||
| Volume | 53,489 shares | KR#972/2,405 Sec#17/56 |
| Trading Value | 395.8M KRW | KR#908/2,405 Sec#17/56 |
| Foreign Own. | 3.19% | KR#1,228/2,405 Sec#22/56 |
| Per Share | ||
| EPS | -52 KRW | KR—/2,405 Sec—/56 |
| BPS | 13,299 KRW | KR#784/2,405 Sec#17/56 |
Company Info
Established in 2004, this company specializes in research and development of health functional food and cosmetic materials, listed on KOSDAQ in 2015. It commercializes natural product-based materials to produce health functional foods and cosmetics via ODM/OEM, operating multiple domestic sites and three overseas corporations in China and Australia, along with subsidiaries H&G Co., Ltd. and Geuno Nongrim Co., Ltd. The company supplies diverse products for immune function improvement, gut health improvement, and blood sugar improvement to 26 countries. Kolmar B&H, established in 2014, is headquartered in Jeonui-myeon, Sejong Special Self-Governing City.